StockData
CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Curanex Pharmaceuticals Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$4.92+0.30 (+6.49%)

Close on Oct 19, 2026

Market cap
$139.55M
P/E (TTM)
–
Dividend yield
–

SEC filings

18 of Curanex Pharmaceuticals's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KSep 14, 2026Oct 19, 2026SEC EDGAR
Current report8-KSep 3, 2026Sep 4, 2026SEC EDGAR
Current report8-KAug 14, 2026Aug 17, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 14, 2026SEC EDGAR
Current report8-KMay 14, 2026May 14, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 14, 2026SEC EDGAR
Current report8-KMay 5, 2026May 7, 2026SEC EDGAR
Current report8-KApr 2, 2026Apr 2, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 30, 2026SEC EDGAR
Current report8-KMar 1, 2026Mar 6, 2026SEC EDGAR
Current report8-KDec 31, 2025Jan 5, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 17, 2025SEC EDGAR
Current report8-KNov 5, 2025Nov 6, 2025SEC EDGAR
Current report8-KSep 23, 2025Sep 29, 2025SEC EDGAR
Current report8-KSep 12, 2025Sep 12, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Sep 9, 2025SEC EDGAR
Current report8-KAug 27, 2025Aug 27, 2025SEC EDGAR
Current report8-KAug 25, 2025Aug 26, 2025SEC EDGAR